• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒策略应侧重于刺激硫酸乙酰肝素的生物合成,而不是抑制其合成。

Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition.

机构信息

La COLOMBE Health Center, Fokoue - Cameroon, 7 rue Eric Tabarly, 91 300 Massy, France.

出版信息

Life Sci. 2021 Jul 15;277:119508. doi: 10.1016/j.lfs.2021.119508. Epub 2021 Apr 15.

DOI:10.1016/j.lfs.2021.119508
PMID:33865880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8046744/
Abstract

Antiviral strategies for viruses that utilize proteoglycan core proteins (syndecans and glypicans) as receptors should focus on heparan sulfate (HS) biosynthesis rather than on inhibition of these sugar chains. Here, we show that heparin and certain xylosides, which exhibit in vitro viral entry inhibitory properties against HSV-1, HSV-2, HPV-16, HPV-31, HVB, HVC, HIV-1, HTLV-1, SARS-CoV-2, HCMV, DENV-1, and DENV-2, stimulated HS biosynthesis at the cell surface 2- to 3-fold for heparin and up to 10-fold for such xylosides. This is consistent with the hypothesis from a previous study that for core protein attachment, viruses are glycosylated at HS attachment sites (i.e., serine residues intended to receive the D-xylose molecule for initiating HS chains). Heparanase overexpression, endocytic entry, and syndecan shedding enhancement, all of which are observed during viral infection, lead to glycocalyx deregulation and appear to be direct consequences of this hypothesis. In addition to the appearance of type 2 diabetes and the degradation of HS observed during viral infection, we linked this hypothesis to that proposed in a previous publication.

摘要

利用蛋白聚糖核心蛋白(连接蛋白和聚糖蛋白)作为受体的病毒的抗病毒策略应侧重于肝素硫酸盐(HS)的生物合成,而不是抑制这些糖链。在这里,我们表明肝素和某些木糖苷,其在体外对 HSV-1、HSV-2、HPV-16、HPV-31、HBV、HCV、HIV-1、HTLV-1、SARS-CoV-2、HCMV、DENV-1 和 DENV-2 具有抑制病毒进入的特性,可在细胞表面将 HS 生物合成刺激 2-3 倍,而对于这些木糖苷,则可刺激高达 10 倍。这与之前研究中的假设一致,即对于核心蛋白附着,病毒在 HS 附着位点发生糖基化(即,用于启动 HS 链的丝氨酸残基接收 D-木糖分子)。肝素酶过表达、内吞进入和连接蛋白脱落增强,这些都在病毒感染过程中观察到,导致糖萼失调,这似乎是该假设的直接后果。除了在病毒感染过程中观察到 2 型糖尿病和 HS 的降解外,我们还将这一假设与之前发表的一篇论文中的假设联系起来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/d689866b7bff/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/f17a7fc27f63/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/ea2a746dd375/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/d7c96dde4b23/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/d689866b7bff/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/f17a7fc27f63/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/ea2a746dd375/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/d7c96dde4b23/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1616/8046744/d689866b7bff/gr3_lrg.jpg

相似文献

1
Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition.抗病毒策略应侧重于刺激硫酸乙酰肝素的生物合成,而不是抑制其合成。
Life Sci. 2021 Jul 15;277:119508. doi: 10.1016/j.lfs.2021.119508. Epub 2021 Apr 15.
2
The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites.丝氨酸蛋白酶抑制剂、OM-85、肝素和可溶性 HS 的 SARS-CoV-2 进入抑制机制可能与 HS 结合位点有关。
Molecules. 2022 Mar 17;27(6):1947. doi: 10.3390/molecules27061947.
3
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.肝素和依诺肝素衍生物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入的有效抑制作用
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01987-20.
4
Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.抗肝素硫酸盐肽可阻断体内单纯疱疹病毒感染。
J Biol Chem. 2011 Jul 15;286(28):25406-15. doi: 10.1074/jbc.M110.201103. Epub 2011 May 19.
5
Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.牛乳铁蛋白通过与硫酸乙酰肝素和低密度脂蛋白受体结合来抑制日本脑炎病毒。
Virology. 2008 Sep 15;379(1):143-51. doi: 10.1016/j.virol.2008.06.017. Epub 2008 Jul 21.
6
Inhibition of three alphaherpesviruses (herpes simplex 1 and 2 and pseudorabies virus) by heparin, heparan and other sulfated polyelectrolytes.肝素、硫酸乙酰肝素及其他硫酸化聚电解质对三种α疱疹病毒(单纯疱疹病毒1型和2型以及伪狂犬病病毒)的抑制作用
Arch Med Res. 1996 Spring;27(1):43-8.
7
Heparanase-1: From Cancer Biology to a Future Antiviral Target.乙酰肝素酶-1:从癌症生物学到未来的抗病毒靶点。
Viruses. 2023 Jan 14;15(1):237. doi: 10.3390/v15010237.
8
Polysulfonate suramin inhibits Zika virus infection.聚磺酸盐苏拉明可抑制寨卡病毒感染。
Antiviral Res. 2017 Jul;143:186-194. doi: 10.1016/j.antiviral.2017.04.017. Epub 2017 Apr 27.
9
Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.双螺环三哌嗪的N,N'-双杂芳基衍生物与细胞表面硫酸乙酰肝素残基的结合特异性地阻止了来自不同家族的病毒感染。
Virology. 2003 Jun 20;311(1):134-43. doi: 10.1016/s0042-6822(03)00166-1.
10
HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection.单纯疱疹病毒1型与小鼠背根神经节外植体中3 - O - 硫酸化硫酸乙酰肝素的相互作用以及病毒感染期间炎症标志物的概况。
J Neurovirol. 2017 Jun;23(3):483-491. doi: 10.1007/s13365-017-0521-4. Epub 2017 Mar 21.

引用本文的文献

1
The effects of metabolites from three vaginal bacteria on the Syndecan-1 of cervical epithelial cells.三种阴道细菌的代谢产物对宫颈上皮细胞Syndecan-1的影响。
Heliyon. 2024 Jun 22;10(12):e33426. doi: 10.1016/j.heliyon.2024.e33426. eCollection 2024 Jun 30.
2
Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy.内皮糖萼损伤在 SARS-CoV-2 感染中的作用:分子机制与潜在靶向治疗。
Mediators Inflamm. 2023 Aug 29;2023:6685251. doi: 10.1155/2023/6685251. eCollection 2023.
3
Reappraising host cellular factors involved in attachment and entry to develop antiviral strategies against porcine reproductive and respiratory syndrome virus.

本文引用的文献

1
Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.iota-卡拉胶和木糖醇可抑制 Vero 细胞培养中的 SARS-CoV-2。
PLoS One. 2021 Nov 19;16(11):e0259943. doi: 10.1371/journal.pone.0259943. eCollection 2021.
2
Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.黏附素在 SARS-CoV-2 细胞进入中的作用。
Int J Mol Sci. 2021 May 19;22(10):5336. doi: 10.3390/ijms22105336.
3
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.昆虫细胞和人细胞中 SARS-CoV-2 刺突蛋白的位点特异性 O-糖基化分析。
重新评估参与猪繁殖与呼吸综合征病毒附着和进入过程的宿主细胞因子,以制定抗病毒策略。
Front Microbiol. 2022 Jul 26;13:975610. doi: 10.3389/fmicb.2022.975610. eCollection 2022.
4
The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites.丝氨酸蛋白酶抑制剂、OM-85、肝素和可溶性 HS 的 SARS-CoV-2 进入抑制机制可能与 HS 结合位点有关。
Molecules. 2022 Mar 17;27(6):1947. doi: 10.3390/molecules27061947.
5
OM-85 Broncho-Vaxom, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells.OM-85 支气管疫苗,一种细菌裂解物,可减少人支气管上皮细胞上的新冠病毒结合蛋白。
Biomedicines. 2021 Oct 26;9(11):1544. doi: 10.3390/biomedicines9111544.
Viruses. 2021 Mar 25;13(4):551. doi: 10.3390/v13040551.
4
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.SARS-CoV-2 刺突蛋白的 N-和 O-糖基化。
Anal Chem. 2021 Feb 2;93(4):2003-2009. doi: 10.1021/acs.analchem.0c03173. Epub 2021 Jan 6.
5
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.肝素抑制 SARS-CoV-2 的细胞侵袭:刺突 S1 受体结合域与肝素相互作用的结构依赖性。
Thromb Haemost. 2020 Dec;120(12):1700-1715. doi: 10.1055/s-0040-1721319. Epub 2020 Dec 23.
6
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.硫酸乙酰肝素有助于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入细胞,并且在体外可被已批准的药物靶向作用。
Cell Discov. 2020 Nov 4;6(1):80. doi: 10.1038/s41421-020-00222-5.
7
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.肝素和依诺肝素衍生物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入的有效抑制作用
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01987-20.
8
Increased Plasma Heparanase Activity in COVID-19 Patients.新型冠状病毒肺炎患者血浆肝素酶活性升高。
Front Immunol. 2020 Oct 6;11:575047. doi: 10.3389/fimmu.2020.575047. eCollection 2020.
9
Global view of human protein glycosylation pathways and functions.人类蛋白糖基化途径和功能的全球视图。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749. doi: 10.1038/s41580-020-00294-x. Epub 2020 Oct 21.
10
Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.内皮糖萼损伤作为 COVID-19 的全身性炎症性微血管内皮病。
Biomed J. 2020 Oct;43(5):399-413. doi: 10.1016/j.bj.2020.08.007. Epub 2020 Aug 24.